|
450. |
Buttgereit, T.*, Vera, C.*, Weller, K., Gutsche, A., Grekowitz, E. M., Aykanat, S., Wahl, V., Krüger, R., Maurer, M.+, and Magerl, M.: Lanadelumab efficacy, safety, and injection interval extension in HAE – a real life study. J. Allergy Clin. Immunol. Pract. 2021: 9; 3744-3751. IF: 11.02 |
o.450
| 426. | Lumry, W. R.+, Weller, K., Magerl, M., Banerji, A., Longhurst, H. J., Riedl, M. A., Lewis, H. B., Lu, P., Devercelli, G., Jain, G., and Maurer, M.: Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study. Allergy 2021: 76; 1188-1198. IF: 14.71 |
o.426
| 330 | Banerji, A.+, Riedl, M. A., Bernstein, J. A., Cicardi, M., Longhurst, H. J., Zuraw, B. L., Busse, P. J., Anderson, J., Magerl, M., Martinez-Saguer, I., Davis-Lorton, M., Zanichelli, A., Li, H., Craig, T., Jacobs, J., Johnston, D. T., Shapiro, R., Yang, W. H., Lumry, W. R., Manning,M. E., Schwartz, L. B., Shennak, M., Soteres, D., Zaragoza-Urdaz, H., Gierer, S., Smith, A. M., Tachdjian, R., Wedner, J., Hebert, J., Rehman, S. M., Staubach, P., Schranz, J., Baptista, J., Nothaft, W., and Maurer, M.: Effect of Lanadelumab compared with placebo on prevention of hereditary angioedema attacks: a randomized clinical trial. JAMA 2018: 320; 2108-2121. IF: 51.27 |